ESCRS - FP25 - EARLY CLINICAL OUTCOMES FOLLOWING RELEX SMILE PRO WITH THE NEW VISUMAX 800

EARLY CLINICAL OUTCOMES FOLLOWING RELEX SMILE PRO WITH THE NEW VISUMAX 800

Published 2022 - 26th ESCRS Winter Meeting

Reference: FP25 | Type: Abstracts | DOI: 10.82333/xcex-8b66

Authors: Supriya Samak Sriganesh* 1 , Sri Ganesh 1 , Sheetal Brar 1

1Phaco and Refractive Surgery,Nethradhama Superspeciality Eye Hospital,Bangalore,India

Purpose

To evaluate the early clinical outcomes following ReLEx SMILE PRO using the Visumax 800 in terms of safety, efficacy and intraoperative complications

Setting

Nethradhama Superspecialty Eye Hospital, Bangalore

Methods

A total of 42 eyes of 21 patients (25.95 ± 2.85 years; mean age ± standard deviation) with a mean spherical equivalent of -3.79 ± 2.33 underwent the ReLEx SMILE Pro procedure using the Visumax 800 machine for correction of myopia. The clinical outcomes were evaluated on post operative day 1 with respect to safety, efficacy and adverse events.

Results

The average pre operative corrected distance visual acuity was -0.07 ± 0.03 logMar, average post operative uncorrected distance visual acuity -0.07 ± 0.06 logMar and corrected post operative distance visual acuity was 0.10± 0.08 logMar. The efficacy index was found to be 1.00 and safety index 1.50. The pre operative OSI was 0.5 and post operative day 1 OSI was 1.135 (p=0.000002). No complications were observed in any of the cases.

Conclusion

Immediate post-op results with the VisuMax 800 demonstrate excellent correction and good visual acuity in terms of efficacy. No eyes had two or more lines loss of CDVA, demonstrating a good safety profile. Quality of vision and interface clarity showed minimal increase in scatter, which is expected to improve over time.